Table 3 The anticoagulant profiles, molecular weights, and plasma half-lives of the commercial low molecular weight heparins discussed
From: Arterial indications for the low molecular weight heparins
| Â | Â | Molecular | Plasma |
|---|---|---|---|
| Â | Anti-Xa:anti-IIa | weight | half-life |
Agent | ratio | (saccharide units) | (min) |
Enoxaparin | 2.7:1 | 4500 | 120–180 |
Dalteparin | 2.0:1 | 5000 | 119–139 |
Nadroparin | 3.2:1 | 4500 | 132–162 |